AF
BIIB icon

Arrow Financial’s Biogen BIIB Stock Holding History

Arrow Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10
Closed -$2K – 324
2019
Q2 		$2K Sell
10
-990
-99% -$229K ﹤0.01% 333
2019
Q1 		$236K Buy
+1,000
New +$315K 0.05% 161
2018
Q4 		– Sell
-1,065
Closed -$376K – 365
2018
Q3 		$376K Buy
1,065
+1,000
+1,538% +$344K 0.08% 146
2018
Q2 		$19K Hold
65
– – ﹤0.01% 262
2018
Q1 		$18K Sell
65
-5,000
-99% -$1.55M ﹤0.01% 268
2017
Q4 		$1.61M Hold
5,065
– – 0.37% 73
2017
Q3 		$1.59M Hold
5,065
– – 0.38% 71
2017
Q2 		$1.38M Hold
5,065
– – 0.33% 78
2017
Q1 		$1.39M Sell
5,065
-1,025
-17% -$290K 0.34% 79
2016
Q4 		$1.73M Sell
6,090
-120
-2% -$35.6K 0.43% 75
2016
Q3 		$1.94M Sell
6,210
-725
-10% -$215K 0.49% 65
2016
Q2 		$1.68M Sell
6,935
-4,202
-38% -$1.11M 0.44% 74
2016
Q1 		$2.9M Sell
11,137
-2,229
-17% -$589K 0.77% 41
2015
Q4 		$4.09M Buy
13,366
+2,649
+25% +$761K 1.09% 26
2015
Q3 		$3.13M Buy
10,717
+1,572
+17% +$519K 0.89% 34
2015
Q2 		$3.69M Buy
9,145
+836
+10% +$336K 1% 33
2015
Q1 		$3.51M Sell
8,309
-456
-5% -$180K 0.94% 34
2014
Q4 		$2.98M Buy
8,765
+3,425
+64% +$1.11M 0.81% 40
2014
Q3 		$1.77M Buy
5,340
+1,000
+23% +$330K 0.49% 70
2014
Q2 		$1.37M Sell
4,340
-2,780
-39% -$837K 0.37% 89
2014
Q1 		$2.18M Sell
7,120
-880
-11% -$279K 0.62% 56
2013
Q4 		$2.24M Buy
8,000
+500
+7% +$129K 0.64% 56
2013
Q3 		$1.81M Hold
7,500
– – 0.55% 64
2013
Q2 		$1.61M Buy
+7,500
New +$1.6M 0.52% 68

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arrow Financial's BIIB Position: Q3 2019 in Review

Arrow Financial sold out of Biogen (BIIB) in Q3 2019, closing a stake of 10 shares — an estimated $2K sold.

Arrow Financial first reported a position in BIIB in Q2 2013 and held it in 24 quarters. The position peaked at $4.09M in Q4 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Arrow Financial reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Arrow Financial sold 10 Biogen shares in Q3 2019, an estimated $2K.
  • Arrow Financial first reported a position in Biogen in Q2 2013 and held it in 24 quarters.
  • Arrow Financial's Biogen position peaked at $4.09M in Q4 2015.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Arrow Financial's 13F filing for Q3 2019, filed 28 Oct 2019.